{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:11:09Z","timestamp":1776474669705,"version":"3.51.2"},"reference-count":49,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OPTH"],"DOI":"10.2147\/opth.s401167","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T04:40:11Z","timestamp":1678768811000},"page":"849-860","source":"Crossref","is-referenced-by-count":6,"title":["Early Lifetime Substance Use and Development of Visual Impairment: Analysis of the National Survey on Drug Use and Health Data"],"prefix":"10.2147","volume":"Volume 17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3436-2651","authenticated-orcid":true,"given":"Zain","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asher","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2136-4650","authenticated-orcid":true,"given":"Asad","family":"Loya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6444-5151","authenticated-orcid":true,"given":"Kaushal","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-4283","authenticated-orcid":true,"given":"Fasika A","family":"Woreta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1090-5025","authenticated-orcid":true,"given":"Kamran M","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,3]]},"reference":[{"key":"ref1","unstructured":"National Survey on Drug Use and Health. Frequently asked questions. Available from: https:\/\/nsduhweb.rti.org\/respweb\/faq.html. Accessed December 1, 2022."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.15585\/mmwr.su6901a1","volume":"69","author":"Underwood","year":"2020","journal-title":"MMWR Suppl"},{"key":"ref3","unstructured":"Substance Abuse and Mental Health Services Administration (US); Office of the Surgeon General (US). Facing addiction in America: the surgeon general\u2019s report on alcohol, drugs, and health. Washington (DC): US Department of Health and Human Services; 2016. Available from: https:\/\/addiction.surgeongeneral.gov\/sites\/default\/files\/surgeon-generals-report.pdf. Accessed December 1, 2022."},{"key":"ref4","unstructured":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Adolescent and School Health. Youth risk behavior survey; 2019. Available from: https:\/\/www.cdc.gov\/healthyyouth\/data\/yrbs\/pdf\/YRBSDataSummaryTrendsReport2019-508.pdf. Accessed December 1, 2022."},{"key":"ref5","first-page":"3493","volume":"62","author":"Andoh","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/ICU.0b013e3283654db2","volume":"24","author":"Peragallo","year":"2013","journal-title":"Curr Opin Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/IJG.0b013e3181f7b134","volume":"20","author":"French","year":"2011","journal-title":"J Glaucoma"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1001\/jamaophthalmol.2020.4741","volume":"139","author":"Mir","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1080\/10550887.2021.1874816","volume":"39","author":"Orum","year":"2021","journal-title":"J Addict Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0891-5520(02)00013-2","volume":"16","author":"Kim","year":"2002","journal-title":"Infect Dis Clin North Am"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.ophtha.2011.11.015","volume":"119","author":"Kim","year":"2012","journal-title":"Ophthalmology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.18502\/jovr.v16i2.9089","volume":"16","author":"Karimi","year":"2021","journal-title":"J Ophthalmic Vis Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/09273948.2020.1726969","volume":"29","author":"Nguyen","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"ref14","unstructured":"Centers for Medicare & Medicare Services. National survey on drug use and health (NSDUH); 2019. Available from: https:\/\/www.cms.gov\/About-CMS\/Agency-Information\/OMH\/resource-center\/hcps-and-researchers\/data-tools\/sgm-clearinghouse\/nsduh. Accessed December 1, 2022."},{"key":"ref15","unstructured":"U.S. Department of Health & Human Services. Substance abuse and mental health services administration (SAMHSA); 2019. Available from: https:\/\/www.samhsa.gov\/. Accessed December 1, 2022."},{"key":"ref16","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). NSDUH data use; 2019. Available from: https:\/\/nsduhweb.rti.org\/respweb\/datause.html. Accessed December 1, 2022."},{"key":"ref17","unstructured":"U.S. Department of Health & Human Services. FY 2021 annual performance plan and report - goal 2 objective 3; 2021. Available from: https:\/\/www.hhs.gov\/about\/budget\/fy2021\/performance\/performance-plan-goal-2-objective-3\/index.html. Accessed December 1, 2022."},{"key":"ref18","unstructured":"Office of National Drug Control Policy. National drug control strategy; 2016. Available from: https:\/\/obamawhitehouse.archives.gov\/ondcp\/policy-and-research\/ndcs#:~:text=The%20National%20Drug%20Control%20Strategy. Accessed December 1, 2022."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/jamaophthalmol.2021.4667","volume":"140","author":"Han","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"ref20","unstructured":"Key substance use and mental health indicators in the United States: results from the 2015 national survey on drug use and health. SAMHSA.gov; 2015. Available from: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-FFR1-2015\/NSDUH-FFR1-2015\/NSDUH-FFR1-2015.pdf. Accessed December 1, 2022."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/02791072.2007.10400612","volume":"39","author":"Kelly","year":"2007","journal-title":"J Psychoactive Drugs"},{"key":"ref22","first-page":"bmjmilitary-2020","volume":"25","author":"McDaniel","year":"2020","journal-title":"BMJ Mil Health"},{"key":"ref23","unstructured":"SAMHDA. National survey on drug use and health 2020 (NSDUH-2020-DS0001); 2020. Available from: https:\/\/www.datafiles.samhsa.gov\/dataset\/national-survey-drug-use-and-health-2020-nsduh-2020-ds0001. Accessed December 1, 2022."},{"key":"ref24","unstructured":"American Academy of Ophthalmology. Survey reveals most Americans know a lot less about eye health than they think they do: here\u2019s why that\u2019s a problem; 2020. Available from: https:\/\/www.aao.org\/newsroom\/news-releases\/detail\/survey-reveals-most-americans-know-less-eye-health. Accessed December 1, 2022."},{"key":"ref25","volume-title":"Robbins and Cotran Pathologic Basis of Diseases","year":"2005"},{"key":"ref26","unstructured":"CDC. Understanding the epidemic: CDC\u2019s response to the opioid overdose epidemic; 2022. Available from: https:\/\/www.cdc.gov\/opioids\/basics\/epidemic.html. Accessed December 1, 2022."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.15585\/mmwr.mm6912a1","volume":"69","author":"Jones","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.drugalcdep.2015.01.029","volume":"149","author":"Palamar","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.drugalcdep.2017.08.036","volume":"180","author":"Butler","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/ICU.0000000000000606","volume":"30","author":"Luong","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","volume":"118","author":"Moss","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/ICO.0b013e31825239d1","volume":"32","author":"Cumurcu","year":"2013","journal-title":"Cornea"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1080\/10826084.2019.1645176","volume":"54","author":"Engster","year":"2019","journal-title":"Subst Use Misuse"},{"key":"ref34","unstructured":"Mayo Clinic. Drug addiction (substance use disorder) - symptoms and causes. Mayo Clinic; 2022. Available from: https:\/\/www.mayoclinic.org\/diseases-conditions\/drug-addiction\/symptoms-causes\/syc-20365112. Accessed December 1, 2022."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1405092","volume":"371","author":"Kandel","year":"2014","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.drugalcdep.2009.12.001","volume":"108","author":"Degenhardt","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"ref37","first-page":"96","volume":"31","author":"Martin","year":"2008","journal-title":"Alcohol Res Health"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/josh.12351","volume":"86","author":"Barry","year":"2016","journal-title":"J Sch Health"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.drugpo.2014.07.011","volume":"26","author":"Secades-Villa","year":"2015","journal-title":"Int J Drug Policy"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1196\/annals.1441.030","volume":"1141","author":"Sinha","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1037\/ccp0000633","volume":"89","author":"Litt","year":"2021","journal-title":"J Consult Clin Psychol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1111\/j.1360-0443.2009.02693.x","volume":"104","author":"Litt","year":"2009","journal-title":"Addiction"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1111\/add.13841","volume":"112","author":"Roos","year":"2017","journal-title":"Addiction"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/jcpp.12783","volume":"59","author":"Gray","year":"2018","journal-title":"J Child Psychol Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.jadohealth.2011.12.033","volume":"50","author":"Feinstein","year":"2012","journal-title":"J Adolesc Health"},{"key":"ref46","first-page":"126","volume":"25","author":"Harris","year":"2014","journal-title":"Adolesc Med State Art Rev"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/eye.2012.205","volume":"26","author":"Han","year":"2012","journal-title":"Eye"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/bjo.2009.165902","volume":"95","author":"Jefferis","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.euroneuro.2017.09.006","volume":"27","author":"Lalanne","year":"2017","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Clinical Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=88157","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=88157","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T04:40:27Z","timestamp":1678768827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/early-lifetime-substance-use-and-development-of-visual-impairment-anal-peer-reviewed-fulltext-article-OPTH"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":49,"URL":"https:\/\/doi.org\/10.2147\/opth.s401167","relation":{},"ISSN":["1177-5483"],"issn-type":[{"value":"1177-5483","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3]]}}}